Martin Woodward

Martin brings over 20 years’ of academic and industrial science experience to his role as Principal Scientist at LIfT. As an experienced immunologist he has published high impact research and has been a founding scientist of biotech start-ups including GammaDelta Therapeutics. Martin is particularly focussed on the challenges in bringing cell therapies from the bench to the clinic, and holds a PhD from University College London.